Zobrazeno 1 - 10
of 49
pro vyhledávání: '"Stanley B, Cohen"'
Autor:
Gerd R. Burmester, Laura C. Coates, Stanley B. Cohen, Yoshiya Tanaka, Ivana Vranic, Edward Nagy, Irina Lazariciu, All-shine Chen, Kenneth Kwok, Lara Fallon, Cassandra Kinch
Publikováno v:
Rheumatology and Therapy, Vol 10, Iss 5, Pp 1255-1276 (2023)
Abstract Introduction The safety of tofacitinib in psoriatic arthritis (PsA) and rheumatoid arthritis (RA) has been demonstrated in clinical studies of ≤ 4 and 9.5 years, respectively. Post-marketing surveillance (PMS) data for tofacitinib from spo
Externí odkaz:
https://doaj.org/article/34b105e8c7c24f45a0dae2316f33af1c
Autor:
Gerd R. Burmester, Laura C. Coates, Stanley B. Cohen, Yoshiya Tanaka, Ivana Vranic, Edward Nagy, Irina Lazariciu, All-shine Chen, Kenneth Kwok, Lara Fallon, Cassandra Kinch
Publikováno v:
Rheumatology and Therapy, Vol 11, Iss 1, Pp 221-222 (2023)
Externí odkaz:
https://doaj.org/article/099e14f76fec48319dad1e2044b6fc13
Autor:
Kevin L. Winthrop, Arne Yndestad, Dan Henrohn, Silvio Danese, Sara Marsal, Maria Galindo, John C. Woolcott, Hyejin Jo, Kenneth Kwok, Andrea B. Shapiro, Thomas V. Jones, Annette Diehl, Chinyu Su, Julian Panés, Stanley B. Cohen
Publikováno v:
Rheumatology and Therapy, Vol 10, Iss 2, Pp 357-373 (2022)
Abstract Introduction This post hoc analysis evaluated influenza adverse events (AEs) across rheumatoid arthritis (RA), ulcerative colitis (UC), and psoriatic arthritis (PsA) tofacitinib clinical programs. Methods Available data from phase 1, randomi
Externí odkaz:
https://doaj.org/article/636def3d7be64a6abbfb716f2f5fce89
Autor:
Peter Nash, Atul Deodhar, Philip J Mease, Yoshiya Tanaka, Tim Shaw, Gerd R Burmester, Kevin L Winthrop, Alan D Irvine, Eduardo Mysler, Stanley B Cohen, Ana P Lacerda, John Liu, Hannah Palac, Emma Guttman‑Yassky
Publikováno v:
RMD Open, Vol 9, Iss 1 (2023)
Objective To evaluate the long-term safety profile for upadacitinib across rheumatoid arthritis (RA), psoriatic arthritis (PsA), ankylosing spondylitis (AS) and atopic dermatitis (AD).Methods Safety data from clinical trials of upadacitinib 15 mg and
Externí odkaz:
https://doaj.org/article/0a14bda1c5df487ca97dad80e6cdb1e7
Autor:
Boulos Haraoui, Janet Pope, Edward C Keystone, Eduardo Mysler, Tatjana Lukic, Harry Shi, Stanley B Cohen, Rebecca Germino, Lori Stockert, Annette Diehl, Sujatha Menon, Shixue Liu
Publikováno v:
RMD Open, Vol 7, Iss 2 (2021)
Objectives To report the efficacy, safety and patient-reported outcome measures (PROs) of tofacitinib modified-release 11 mg once daily plus methotrexate in patients with rheumatoid arthritis (RA) from the open-label phase of Oral Rheumatoid Arthriti
Externí odkaz:
https://doaj.org/article/b9866211020a40c7b198924289c15f38
Autor:
Peter Nash, Yoshiya Tanaka, Kevin L Winthrop, Eun Bong Lee, Xavier Mariette, Jeffrey R Curtis, Kenneth Kwok, Connie Chen, Pinaki Biswas, Lisy Wang, Christina Charles-Schoeman, Ann Madsen, Stanley B Cohen, Andrea Shapiro, Jürgen Wollenhaupt
Publikováno v:
RMD Open, Vol 6, Iss 3 (2020)
Objective Tofacitinib is an oral Janus kinase (JAK) inhibitor for the treatment of rheumatoid arthritis (RA). We report the largest integrated safety analysis of tofacitinib, as of March 2017, using data from phase I, II, III, IIIb/IV and long-term e
Externí odkaz:
https://doaj.org/article/06d315c88fb8416d89479fa698afb87f
Autor:
Stanley B. Cohen, Rieke Alten, Hideto Kameda, Tomas Hala, Sebastiao C. Radominski, Muhammad I. Rehman, Ramesh Palaparthy, Karl Schumacher, Susanne Schmitt, Steven Y. Hua, Claudia Ianos, K. Lea Sewell
Publikováno v:
Arthritis Research & Therapy, Vol 20, Iss 1, Pp 1-13 (2018)
Abstract Background This double-blind, active-controlled, randomized, multinational study evaluated the efficacy, safety, pharmacokinetics (PK), and immunogenicity of PF-06438179/GP1111 (IxifiTM/Zessly®), an infliximab biosimilar, vs infliximab (Rem
Externí odkaz:
https://doaj.org/article/467cbd7fd59e48078e3d671474187104
Autor:
Stanley B Cohen, Eric C Lee
Publikováno v:
Immunotherapy. 14:1183-1190
Summary What is this summary about? Here, we summarize the results from the VOLTAIRE-RA study, originally published in the journal Annals of the Rheumatic Diseases. The VOLTAIRE-RA study looked at how effective and safe BI 695501 is in treating peopl
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::1bcf3b4be8fe1d2cc308143db1a27a38
https://doi.org/10.2217/imt-2022-0106
https://doi.org/10.2217/imt-2022-0106
Autor:
Kevin L. Winthrop, Stanley B. Cohen
Publikováno v:
Nature Reviews Rheumatology. 18:301-304
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::37708436fe8748fb49925ec379e3aa10
https://doi.org/10.1038/s41584-022-00767-7
https://doi.org/10.1038/s41584-022-00767-7
Autor:
Ruediger B. Mueller, Hendrik Schulze-Koops, Daniel E. Furst, Stanley B. Cohen, Kenneth Kwok, Lisy Wang, Tim Killeen, Johannes von Kempis
Publikováno v:
Clinical Rheumatology. 41:1045-1055
Introduction/objectives We assess the impact of switching versus staying on the same tofacitinib dose on efficacy and safety in patients with rheumatoid arthritis (RA). Methods ORAL Sequel was an open-label, long-term extension study of patients with
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::2cde326cd84546180ea96bdb8fef278e
https://doi.org/10.1007/s10067-021-05908-z
https://doi.org/10.1007/s10067-021-05908-z